These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11051739)

  • 1. [Diagnostic implications of extracellular matrix proteins in chronic hepatitis and hepatic cirrhosis].
    Dudanova OP
    Klin Med (Mosk); 2000; 78(9):40-3. PubMed ID: 11051739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma tissue inhibitor of metalloproteinases-1 and transforming growth factor beta 1--possible non-invasive biomarkers of hepatic fibrosis in patients with chronic B and C hepatitis.
    Flisiak R; Maxwell P; Prokopowicz D; Timms PM; Panasiuk A
    Hepatogastroenterology; 2002; 49(47):1369-72. PubMed ID: 12239944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Diagnostic significance of type IV collagen and hyaluronic acid in the serum of patients with chronic hepatitis C for staging hepatic fibrosis].
    Iushchuk ND; Znoĭko OO; Safiullina NKh; Dudina KR; Kelli EI; Klimova EA; Kashirin VI; Braginskiĭ DM; Kushlinskiĭ NE; Liubimova NV; Vasilev AIu; Penkina TV; Danilin AG
    Ter Arkh; 2005; 77(4):50-5. PubMed ID: 15938533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
    Zhang W; Yue B; Wang GQ; Lu SL
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):577-80. PubMed ID: 14607690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of serum fibrosis indexes in patients with chronic hepatitis and its significance.
    Zheng M; Cai W; Weng H; Liu R
    Chin Med J (Engl); 2003 Mar; 116(3):346-9. PubMed ID: 12781034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biochemical markers of fibrosis in chronic hepatitis and liver cirrhosis of viral origin].
    Kozłowska J; Łoch T; Jabłońska J; Cianciara J
    Przegl Epidemiol; 2001; 55(4):451-8. PubMed ID: 11921731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical value of measuring the activity of serum cholinesterase and its isoenzyme in chronic hepatitis and liver cirrhosis].
    Karlinskiĭ VM; Breĭdo EV; Falikovich MIa; Iskakov BS; Beĭsetaev OB; Baranov NP; Bekenova FK
    Klin Med (Mosk); 1991 Jun; 69(6):85-7. PubMed ID: 1774923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum thrombopoietin levels in patients with chronic hepatitis and liver cirrhosis, and its relationship with circulating thrombocyte counts.
    Koruk M; Onuk MD; Akçay F; Savas MC
    Hepatogastroenterology; 2002; 49(48):1645-8. PubMed ID: 12397754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Serum concentration and antiviral activity of interferon alpha in chronic hepatitis and liver cirrhosis].
    Levitan BN; Astakhin AV; Chishieva EM; Afanas'ev SS
    Voen Med Zh; 2004 Feb; 325(2):60-6, 96. PubMed ID: 15101297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
    Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical implications of measurement of serum nuclear matrix protein levels in patients with liver disease.
    Shimizu Y; Nakano I; Katano Y; Shimizu H; Fukuda Y
    Hepatogastroenterology; 2005; 52(66):1809-13. PubMed ID: 16334782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The protein C system in chronic hepatic diseases, and anti-viral therapy].
    Koroĭ PV
    Klin Med (Mosk); 2008; 86(2):63-6. PubMed ID: 18368797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical use of serum markers of fibrosis in chronic hepatitis.
    Trinchet JC
    J Hepatol; 1995; 22(2 Suppl):89-95. PubMed ID: 7665855
    [No Abstract]   [Full Text] [Related]  

  • 14. [A quantitative study of the relationship between levels of liver fibrosis markers in sera and fibrosis stages of liver tissues of patients with chronic hepatic diseases].
    Ding XJ; Li SB; Li SZ; Liu HS; Liu B; Xu FM; Gu RW
    Zhonghua Gan Zang Bing Za Zhi; 2005 Dec; 13(12):911-4. PubMed ID: 16381637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of serum paraoxonase-1 activity as a potential biomarker for chronic liver impairment.
    Camps J; Marsillach J; Joven J
    Clin Chim Acta; 2007; 386(1-2):114-5. PubMed ID: 17850780
    [No Abstract]   [Full Text] [Related]  

  • 16. Determination of serum fibrosis index in patients with chronic hepatitis and its relationship to histological activity index.
    Elmetwally IM; Elmahalaway AM; Abuhashem SH; Ahmed AM
    Saudi Med J; 2009 May; 30(5):638-46. PubMed ID: 19417962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tenascin-C in chronic canine hepatitis: immunohistochemical localization and correlation with necro-inflammatory activity, fibrotic stage, and expression of alpha-smooth muscle actin, cytokeratin 7, and CD3+ cells.
    Mekonnen GA; Ijzer J; Nederbragt H
    Vet Pathol; 2007 Nov; 44(6):803-13. PubMed ID: 18039893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic accuracy of a fibrosis serum panel (FIBROSpect II) compared with Knodell and Ishak liver biopsy scores in chronic hepatitis C patients.
    Christensen C; Bruden D; Livingston S; Deubner H; Homan C; Smith K; Oh E; Gretch D; Williams J; McMahon B
    J Viral Hepat; 2006 Oct; 13(10):652-8. PubMed ID: 16970596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of five serum markers for liver fibrosis].
    Luo R; Yang S; Xie J; Zhao Z; He Y; Yao J
    Zhonghua Gan Zang Bing Za Zhi; 2001 Jun; 9(3):148-50. PubMed ID: 11412388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The calcium content in the bile of patients with cholelithiasis, chronic hepatitis, liver cirrhosis and in healthy subjects].
    Dzhuraev KhSh; Merkul'eva NR; Kazakova NM
    Lab Delo; 1990; (1):23-4. PubMed ID: 1691331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.